R&D News | pharmaphorum

News

health care icon pattern medical innovation concept background design

UK health innovations get £23m funding

The UK government’s Biomedical Catalyst (BMC) programme has announced £23 million of funding for cutting edge health projects, including new software which enables radiologists to diagnose

News

AI drug R&D firm Exscientia expands into Japan

AI drug R&D firm Exscientia has announced it has expanded into Japan, after clinching a major research deal with Celgene.

News

Closeup of X-ray photography of human brain

Biogen, Eisai hit hard as Alzheimer’s drug is abandoned

The dwindling number of amyloid-targeting drugs in development for Alzheimer’s disease (AD) has been reduced by one more, after Biogen and Eisai pulled the plug on aducanumab.

News

UK biotech industry booms on record investment - analysis

UK biotech is booming, with the number of R&D companies increasing 65% since 2016 amid soaring annual investment of more than £2 billion, according to a new report.

News

Alexion signs R&D deals with two Nordic biotechs

Alexion has signed a deal with two Nordic biotechs to bolster its pipeline of potential rare disease drugs.

News

UK pharma patents up 20%, new report finds

The pharma industry saw double-digit growth in patent filings for the second year in a row in 2018, with applications from the UK up by a fifth, according to the latest

UK health innovations get £23m funding

AI drug R&D firm Exscientia expands into Japan

Biogen, Eisai hit hard as Alzheimer’s drug is abandoned

UK biotech industry booms on record investment - analysis

Alexion signs R&D deals with two Nordic biotechs

UK pharma patents up 20%, new report finds

AZ boosts vaccine capabilities with Omniose buy

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks